Mannkind Corp

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$3.94

+0.01 (+0.25%)

As of Jun 24, 1:36 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 86%

Hold 2 14%

Sell 0 0%

Price Target

Analyst Price Target +702.3% upside

Low Target $20.51

Average Target $31.61

High Target $34.61

Current Price $3.94

Current
$3.94

Target
$31.61

$20.51 $31.61 avg $34.61

Scenario Analysis

Bear Case

$20.51

420.6%

Low target

Base Case

$31.61

+702.3%

Avg target

Bull Case

$34.61

+778.4%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$6.51

-39.5% from high

52-Week Low

$2.23

+76.7% from low

Target vs 52W High

$31.61

+385.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.7%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+189.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-7.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-65.2%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.8%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-45.0%